These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 31553973)

  • 1. Changes in FGF-23, Neutrophil/Platelet Activation Markers, and Angiogenin in Advanced Chronic Kidney Disease and Their Effect on Arterial Stiffness.
    Choi HM; Kwon YE; Kim S; Oh DJ
    Kidney Blood Press Res; 2019; 44(5):1166-1178. PubMed ID: 31553973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progression of arterial stiffness is associated with changes in bone mineral markers in advanced CKD.
    Krishnasamy R; Tan SJ; Hawley CM; Johnson DW; Stanton T; Lee K; Mudge DW; Campbell S; Elder GJ; Toussaint ND; Isbel NM
    BMC Nephrol; 2017 Sep; 18(1):281. PubMed ID: 28870151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Association of Fibroblast Growth Factor 23 with Arterial Stiffness and Atherosclerosis in Patients with Autosomal Dominant Polycystic Kidney Disease.
    Coban M; Inci A; Yılmaz U; Asilturk E
    Kidney Blood Press Res; 2018; 43(4):1160-1173. PubMed ID: 30064143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aortic Calcification and Arterial Stiffness Burden in a Chronic Kidney Disease Cohort with High Cardiovascular Risk: Baseline Characteristics of the Impact of Phosphate Reduction On Vascular End-Points in Chronic Kidney Disease Trial.
    Lioufas NM; Pedagogos E; Hawley CM; Pascoe EM; Elder GJ; Badve SV; Valks A; Toussaint ND;
    Am J Nephrol; 2020; 51(3):201-215. PubMed ID: 32023606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of the morphogenetic proteins FGF-23 and Klotho and the glycoprotein sclerostin in the assessment of the risk of cardiovascular diseases and the prognosis of chronic kidney disease].
    Milovanova LY; Milovanov YS; Kudryavtseva DV; Markina MM; Milovanova SY; Kozlovskaya LV; Lebedeva MV; Beketov VD; Moiseev SV; Mukhin NA; Fomin VV; Svistunov AA
    Ter Arkh; 2015; 87(6):10-16. PubMed ID: 26281189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of arterial stiffness in chronic kidney disease stage 3.
    McIntyre NJ; Fluck RJ; McIntyre CW; Fakis A; Taal MW
    PLoS One; 2013; 8(1):e55444. PubMed ID: 23383192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized Controlled Trial for the Effect of Vitamin D Supplementation on Vascular Stiffness in CKD.
    Levin A; Tang M; Perry T; Zalunardo N; Beaulieu M; Dubland JA; Zerr K; Djurdjev O
    Clin J Am Soc Nephrol; 2017 Sep; 12(9):1447-1460. PubMed ID: 28550081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mild chronic kidney disease associated with greater risk of arterial stiffness in elderly adults.
    Liu IT; Wu JS; Yang YC; Huang YH; Lu FH; Chang CJ
    J Am Geriatr Soc; 2013 Oct; 61(10):1758-62. PubMed ID: 24083328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of serum adiponectin concentration with aortic arterial stiffness in chronic kidney disease: from the KNOW-CKD study.
    Kim CS; Bae EH; Ma SK; Park SK; Lee JY; Chung W; Lee K; Kim YH; Oh KH; Ahn C; Kim SW;
    Clin Exp Nephrol; 2017 Aug; 21(4):608-616. PubMed ID: 27514393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of vitamin D supplementation on arterial vasomotion, stiffness and endothelial biomarkers in chronic kidney disease patients.
    Chitalia N; Ismail T; Tooth L; Boa F; Hampson G; Goldsmith D; Kaski JC; Banerjee D
    PLoS One; 2014; 9(3):e91363. PubMed ID: 24646518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations Between Kidney Disease Measures and Regional Pulse Wave Velocity in a Large Community-Based Cohort: The Atherosclerosis Risk in Communities (ARIC) Study.
    Kim ED; Tanaka H; Ballew SH; Sang Y; Heiss G; Coresh J; Matsushita K
    Am J Kidney Dis; 2018 Nov; 72(5):682-690. PubMed ID: 30007506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of arterial stiffness in nondiabetic chronic kidney disease patients.
    Mastanvalli B; Kumar KP; Madhav D; Venkata Pakki Reddy PL; Vali SM
    Saudi J Kidney Dis Transpl; 2017; 28(1):61-67. PubMed ID: 28098104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum bone markers in ROD patients across the spectrum of decreases in GFR: Activin A increases before all other markers
.
    Lima F; Mawad H; El-Husseini AA; Davenport DL; Malluche HH
    Clin Nephrol; 2019 Apr; 91(4):222-230. PubMed ID: 30862350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulse wave velocity differs between ulcerative colitis and chronic kidney disease.
    Zanoli L; Lentini P; Boutouyrie P; Fatuzzo P; Granata A; Corrao S; Gaudio A; Inserra G; Rapisarda F; Rastelli S; Laurent S; Malatino LS; Castellino P
    Eur J Intern Med; 2018 Jan; 47():36-42. PubMed ID: 28830726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mean platelet volume and its relation with arterial stiffness in patients with normotensive polycystic kidney disease.
    Orscelik O; Kocyigit I; Akpek M; Dogdu O; Kaya C; Unal A; Sipahioglu M; Tokgoz B; Zengin H; Oymak O; Kaya MG
    J Investig Med; 2013 Mar; 61(3):597-603. PubMed ID: 23360844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced glycation end products and arterial stiffness in patients with diabetic nephropathy and patients with chronic kidney disease without diabetes.
    Stróżecki P; Kurowski R; Flisiński M; Stefańska A; Odrowąż-Sypniewska G; Manitius J
    Pol Arch Med Wewn; 2013; 123(11):609-16. PubMed ID: 24036618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arterial Stiffness Assessed by Oscillometric Method in Kidney Transplant, Predialysis, and Dialysis Patients.
    Olczyk P; Małyszczak A; Gołębiowski T; Letachowicz K; Szymczak A; Mazanowska O; Krajewska M; Kusztal M
    Transplant Proc; 2020 Oct; 52(8):2337-2340. PubMed ID: 32359829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin resistance and the metabolic syndrome are associated with arterial stiffness in patients with chronic kidney disease.
    Chan DT; Watts GF; Irish AB; Ooi EM; Dogra GK
    Am J Hypertens; 2013 Sep; 26(9):1155-61. PubMed ID: 23736110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aortic pulse wave velocity, central pulse pressure, augmentation index and chronic kidney disease progression in individuals with type 2 diabetes: a 3- year prospective study.
    Liu JJ; Liu S; Lee J; Gurung RL; Yiamunaa M; Ang K; Shao YM; Choo RWM; Tavintharan S; Tang WE; Sum CF; Lim SC
    BMC Nephrol; 2020 Aug; 21(1):359. PubMed ID: 32819303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arterial stiffness and 25-hydroxyvitamin D levels in chronic kidney disease patients.
    Akdam H; Alp A
    Rev Assoc Med Bras (1992); 2017 Oct; 63(10):910-916. PubMed ID: 29267494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.